The FDA has approved the NDA for SH-201, an oral liquid drug that slows or stops...
In an interview with Pharmaceutical Technology, Pluri’s CEO discussed its recent...
Despite a failed bid to expand Imfinzi’s treatment scope in NSCLC, the drug has ...
GSK’s Trelegy Ellipta has been approved as a maintenance therapy for both asthma...
Last month, Amylyx announced that the Phase III confirmatory trial of ALS drug R...
Recent campaigns have targeted children and young adults in low vaccine uptake a...
Acumen has entered a partnership with Lonza to further the development of sabirn...
MiNA Therapeutics has entered into an agreement with Nippon Shinyaku to develop ...
Caris Life Sciences has entered a collaboration with Merck KGaA for the developm...
The UK MHRA has approved Advanz Pharma’s combined antibiotic, cefepime/enmetazob...
The director of BARDA’s medical countermeasures programs, Robert Johnson, talks ...
Discover Chiesi Farmaceutici's innovative patent for a specialized pharmaceutica...
Discover how F. Hoffmann-La Roche's patented system uses nanopores to identify n...
Discover how Incyte Corp's patent targets adenosine receptors to treat cancer, i...
Discover the innovative wrist brace by HCA Healthcare Inc, featuring a unique la...
Discover a groundbreaking method for treating pulmonary hypertension with stem c...
